Rokeya Tasneen

2.5k total citations
35 papers, 1.7k citations indexed

About

Rokeya Tasneen is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Rokeya Tasneen has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 24 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in Rokeya Tasneen's work include Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (15 papers) and Cancer therapeutics and mechanisms (11 papers). Rokeya Tasneen is often cited by papers focused on Tuberculosis Research and Epidemiology (30 papers), Mycobacterium research and diagnosis (15 papers) and Cancer therapeutics and mechanisms (11 papers). Rokeya Tasneen collaborates with scholars based in United States, France and China. Rokeya Tasneen's co-authors include Eric L. Nuermberger, Kathy N. Williams, Sandeep Tyagi, J Grosset, Khisimuzi Mdluli, Deepak V. Almeida, Charles A. Peloquin, Si-Yang Li, Ian M. Rosenthal and Paul J. Converse and has published in prestigious journals such as Nature Communications, American Journal of Respiratory and Critical Care Medicine and The Journal of Infectious Diseases.

In The Last Decade

Rokeya Tasneen

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rokeya Tasneen United States	20	1.4k	998	616	367	189	35	1.7k
Kathy N. Williams United States	19	1.6k 1.1×	1.2k 1.2×	729 1.2×	455 1.2×	188 1.0×	28	1.9k
Jansy P. Sarathy United States	20	1.2k 0.8×	810 0.8×	541 0.9×	232 0.6×	200 1.1×	38	1.5k
Dominique J. Wiener United States	15	1.1k 0.7×	697 0.7×	470 0.8×	280 0.8×	168 0.9×	20	1.5k
Ian M. Rosenthal United States	13	1.1k 0.8×	838 0.8×	417 0.7×	336 0.9×	112 0.6×	18	1.3k
Si-Yang Li United States	18	979 0.7×	819 0.8×	416 0.7×	228 0.6×	140 0.7×	27	1.2k
Veronica Gruppo United States	18	989 0.7×	723 0.7×	582 0.9×	184 0.5×	138 0.7×	19	1.4k
Sang Nae Cho South Korea	15	1.1k 0.8×	828 0.8×	405 0.7×	359 1.0×	135 0.7×	28	1.4k
Luc Vranckx Belgium	10	1.1k 0.8×	849 0.9×	738 1.2×	177 0.5×	255 1.3×	10	1.5k
Radha Krishan Shandil India	15	729 0.5×	468 0.5×	442 0.7×	147 0.4×	146 0.8×	40	1.1k
Tetsuyuki Yoshimatsu Japan	11	1.1k 0.8×	850 0.9×	412 0.7×	337 0.9×	172 0.9×	23	1.3k

Countries citing papers authored by Rokeya Tasneen

Since Specialization

Citations

This map shows the geographic impact of Rokeya Tasneen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rokeya Tasneen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rokeya Tasneen more than expected).

Fields of papers citing papers by Rokeya Tasneen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rokeya Tasneen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rokeya Tasneen. The network helps show where Rokeya Tasneen may publish in the future.

Co-authorship network of co-authors of Rokeya Tasneen

This figure shows the co-authorship network connecting the top 25 collaborators of Rokeya Tasneen. A scholar is included among the top collaborators of Rokeya Tasneen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rokeya Tasneen. Rokeya Tasneen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strydom, Natasha, Marjorie Z. Imperial, Qianwen Wang, et al.. (2024). Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature Communications. 15(1). 7311–7311. 7 indexed citations

Encinas, Lourdes, Si-Yang Li, Rokeya Tasneen, et al.. (2024). Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis. Antimicrobial Agents and Chemotherapy. 68(11). e0035724–e0035724. 3 indexed citations

Tasneen, Rokeya, et al.. (2023). Long-term effects of prenatal arsenic exposure from gestational day 9 to birth on lung, heart, and immune outcomes in the C57BL/6 mouse model. Toxicology Letters. 383. 17–32. 2 indexed citations

Bauman, Allison, Karen Rossmassler, Martin I. Voskuil, et al.. (2022). Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrobial Agents and Chemotherapy. 66(4). e0231021–e0231021. 12 indexed citations

Kaushik, Amit, Nicole C. Ammerman, Rokeya Tasneen, et al.. (2021). Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy. American Journal of Respiratory and Critical Care Medicine. 205(5). 570–579. 9 indexed citations

Tasneen, Rokeya, Deborah S. Mortensen, Paul J. Converse, et al.. (2021). Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(7). e0025321–e0025321. 13 indexed citations

Almeida, Deepak V., Paul J. Converse, Till F. Omansen, et al.. (2020). Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model. Antimicrobial Agents and Chemotherapy. 64(6). 19 indexed citations

Xu, Jian, Si-Yang Li, Deepak V. Almeida, et al.. (2019). Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 63(5). 71 indexed citations

Lun, Shichun, Rokeya Tasneen, Jozef Stec, et al.. (2019). Advancing the Therapeutic Potential of Indoleamides for Tuberculosis. Antimicrobial Agents and Chemotherapy. 63(7). 14 indexed citations

10.

Xu, Jian, Rokeya Tasneen, Charles A. Peloquin, et al.. (2017). Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(1). 36 indexed citations

11.

Park, Sang‐Won, Rokeya Tasneen, Paul J. Converse, & Eric L. Nuermberger. (2017). Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis. Antimicrobial Agents and Chemotherapy. 61(11). 3 indexed citations

12.

Gopal, Pooja, Rokeya Tasneen, Michelle Yee, et al.. (2017). In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1. ACS Infectious Diseases. 3(7). 492–501. 30 indexed citations

13.

Lanoix, Jean‐Philippe, Rokeya Tasneen, Paul E. O’Brien, et al.. (2016). High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 60(7). 4197–4205. 18 indexed citations

14.

Tasneen, Rokeya, et al.. (2014). Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 59(1). 129–135. 47 indexed citations

15.

Harper, Jamie, Ciaran Skerry, S. Lindsey Davis, et al.. (2011). Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions. The Journal of Infectious Diseases. 205(4). 595–602. 183 indexed citations

16.

Ahmad, Zahoor, Eric Nuermberger, Rokeya Tasneen, et al.. (2010). Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. Journal of Antimicrobial Chemotherapy. 65(4). 729–734. 42 indexed citations

17.

Williams, Kathy N., Steven J. Brickner, C. Kendall Stover, et al.. (2009). Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(4). 371–376. 95 indexed citations

18.

Tasneen, Rokeya, Sandeep Tyagi, Kathy N. Williams, J Grosset, & Eric L. Nuermberger. (2008). Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 52(10). 3664–3668. 77 indexed citations

19.

Williams, Kathy N., C. Kendall Stover, Tong Zhu, et al.. (2008). Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model. Antimicrobial Agents and Chemotherapy. 53(4). 1314–1319. 160 indexed citations

20.

Nuermberger, Eric, Sandeep Tyagi, Rokeya Tasneen, et al.. (2008). Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 52(4). 1522–1524. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact